Brief: Vaxcyte Q2 Operating Expenses USD 302.777 Million
BRIEF-Vaxcyte Q2 Operating Expenses USD 302.777 Million Aug 05 (Reuters) - Vaxcyte Q2 net income USD -284.302 million vs. IBES estimate USD -298.3 million.
BRIEF-Vaxcyte Q2 Operating Expenses USD 302.777 Million Aug 05 (Reuters) - Vaxcyte Q2 net income USD -284.302 million vs. IBES estimate USD -298.3 million.